CBGM

Advertisement

cGxPJobs Banner

Glucotrack Announces FDA IDE Submission for Implantable Continuous Blood Glucose Monitoring Technology

RUTHERFORD, N.J., May 7, 2026 Glucotrack, Inc. announced the submission of an Investigational Device Exemption (IDE) application to the...

By cGxPwire Editor
May 9, 2026

Read More

Glucotrack Targets FDA IDE for CBGM Trial in 2026

RUTHERFORD, N.J., March 27, 2026 GlucoTrack announced plans to submit an Investigational Device Exemption (IDE) application to the U.S....

By cGxPwire Editor
March 30, 2026

Read More

Advertisement

cGxPJobs

Directory